ELAVL1 and breast carcinoma: Insights from a study on breast cancer bone metastasis suggest that in a mouse model of experimental metastasis, HuR knockdown significantly inhibited MDA-MB-231 cell-induced tumor growth in the tibial bone marrow and osteolysis [149].